trimethoprim has been researched along with chloramphenicol succinate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, DL; He, H; Lovett, ST; Shy, A; Sun, S; Wang, J; Wu, D; Xu, B; Xu, J; Zhan, W | 1 |
| Chaowagul, W; Dance, DA; Pitakwatchara, N; Wattanagoon, Y; White, NJ; Wuthiekanun, V | 1 |
1 trial(s) available for trimethoprim and chloramphenicol succinate
| Article | Year |
|---|---|
Halving of mortality of severe melioidosis by ceftazidime.
Topics: Actuarial Analysis; Administration, Oral; Adolescent; Adult; Aged; Ceftazidime; Child; Chloramphenicol; Clinical Trials as Topic; Doxycycline; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Melioidosis; Middle Aged; Prospective Studies; Random Allocation; Sepsis; Sulfamethoxazole; Time Factors; Trimethoprim | 1989 |
1 other study(ies) available for trimethoprim and chloramphenicol succinate
| Article | Year |
|---|---|
Structure-Activity Relationship of Peptide-Conjugated Chloramphenicol for Inhibiting
Topics: Anti-Bacterial Agents; Chloramphenicol; Escherichia coli; Microbial Sensitivity Tests; Peptides; Structure-Activity Relationship | 2019 |